Skip to main content

Prion-like aspects of cerebral amyloidosis

The commonality of many neurodegenerative disorders is the predictable temporal occurrence and progression of specific aggregated proteins in the brain. The hallmark proteopathy is Alzheimer’s disease in which aggregated amyloid-β peptide (Aβ) is deposited in the brain parenchyma as amyloid plaques. Multiple evidence suggests that β-amyloidosis is induced by aggregated Aβ which can spread within and among brain regions and act as corruptive templates (seeds) that induce a chain-reaction of Aβ misfolding and aggregation. The insight that the prion paradigm may also apply to cerebral β-amyloidosis and other proteopathies suggests new avenues in search of biomarkers and novel therapeutic strategies.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Mathias Jucker.

Rights and permissions

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and Permissions

About this article

Cite this article

Jucker, M., Ye, L. & Fritschi, S. Prion-like aspects of cerebral amyloidosis. Mol Neurodegeneration 8, O21 (2013). https://doi.org/10.1186/1750-1326-8-S1-O21

Download citation

Keywords

  • Peptide
  • Brain Region
  • Therapeutic Strategy
  • Amyloidosis
  • Neurodegenerative Disorder